IMMUNOSUPPRESSION IN PATIENTS WITH METASTATIC SQUAMOUS-CELL CARCINOMA FROM THE SKIN

被引：28

作者：

DINEHART, SM

CHU, DZJ

MANERS, AW

POLLACK, SV

机构：

[1] UNIV ARKANSAS MED SCI HOSP,DEPT SURG,LITTLE ROCK,AR 72205

[2] UNIV ARKANSAS MED SCI HOSP,DEPT RADIAT MED,LITTLE ROCK,AR 72205

[3] DUKE UNIV,MED CTR,DIV DERMATOL,DURHAM,NC 27710

来源：

JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY | 1990年 / 16卷 / 03期

关键词：

D O I：

10.1111/j.1524-4725.1990.tb03963.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Abstract. Sixteen of 70 patients with metastatic squamous cell carcinoma (SCC) from the skin had evidence of clinical immunosuppression. In addition to patients with lymphoproliferative disorders or renal failure, those with cicatricial pemphigoid and those undergoing chronic oral corticosteroid therapy were identified as being at high risk. Host immune surveillance appears to play a major role in determining the metastatic potential of cutaneous SCC. 1990 American Society for Dermatologic Surgery, Inc.

引用

页码：271 / 274

页数：4

共 18 条

[1] CUTANEOUS MALIGNANCIES AND METASTATIC SQUAMOUS-CELL CARCINOMA FOLLOWING TOPICAL THERAPIES FOR MYCOSIS-FUNGOIDES [J].